Company Overview - Dave Inc. (DAVE) shares increased by 3.6% to close at $192.06, following a notable trading volume that exceeded typical levels, contrasting with a 5.8% loss over the past four weeks [1] - The rally in DAVE's stock price is attributed to investor confidence in the company's growth trajectory and momentum buying due to strong earnings history and favorable price targets [1] Earnings Expectations - DAVE is projected to report quarterly earnings of $3.19 per share, reflecting a year-over-year increase of 56.4%, with revenues expected to reach $155.53 million, up 54.2% from the same quarter last year [2] - The consensus EPS estimate for DAVE has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] Industry Context - DAVE Inc. is part of the Zacks Technology Services industry, where another company, Coherent (COHR), saw its stock rise by 6.4% to $195.96, with an 8% return over the past month [3] - Coherent's consensus EPS estimate for its upcoming report is $1.21, representing a year-over-year change of 27.4%, and it currently holds a Zacks Rank of 3 (Hold) [4]

Core Viewpoint - Analysts project that Associated Banc-Corp (ASB) will report quarterly earnings of $0.69 per share, reflecting a year-over-year increase of 21.1%, with revenues expected to reach $379.7 million, a 9.8% increase from the same quarter last year [1] Earnings Projections - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1] - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [2] Key Metrics Estimates - Analysts estimate the 'Adjusted efficiency ratio' at 55.7%, down from 61.1% a year ago [3] - The 'Average Balance - Total earning assets and related interest income' is projected to be $40.77 billion, up from $38.88 billion year-over-year [4] - 'Nonaccrual loans' are expected to be $111.94 million, down from $123.26 million last year [4] - 'Total nonperforming assets' are projected at $136.47 million, compared to $144.16 million a year ago [4] Income and Fees Estimates - 'Total Noninterest Income' is expected to be $69.99 million, down from $71.82 million in the same quarter last year [5] - 'Mortgage banking, net' is projected at $3.28 million, compared to $3.39 million last year [5] - 'Card-based fees' are expected to reach $12.04 million, up from $11.95 million a year ago [6] - 'Service charges and deposit accounts fees' are projected at $13.16 million, slightly down from $13.23 million last year [6] Interest Income Estimates - 'Net Interest Income (FTE)' is expected to be $310.73 million, up from $273.97 million in the same quarter last year [7] - 'Wealth management fees' are projected at $24.50 million, compared to $24.10 million last year [7] Other Revenue Estimates - 'Capital markets, net' is estimated at $6.03 million, down from $9.03 million a year ago [8] - 'Other fee-based revenue' is projected to reach $5.08 million, slightly down from $5.18 million last year [8] Stock Performance - Over the past month, shares of Associated Banc-Corp have returned +0.4%, while the Zacks S&P 500 composite has changed by +2% [8] - ASB currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Wall Street analysts forecast that Old Republic International (ORI) will report quarterly earnings of $0.89 per share in its upcoming release, pointing to a year-over-year decline of 1.1%. It is anticipated that revenues will amount to $2.31 billion, exhibiting an increase of 7.3% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this t ...

Company Overview - Profound Medical (PROF) shares increased by 9.5% to close at $8.34, with trading volume significantly higher than usual, contrasting with a 0.3% loss over the past four weeks [1] - The rise in share price followed the successful treatment of a prostate cancer patient at Mount Sinai Hospital using the TULSA-PRO system, which integrates advanced technologies for treatment [2] Financial Performance - The company is projected to report a quarterly loss of $0.28 per share, reflecting a year-over-year decline of 40%, while revenues are expected to reach $8 million, marking a 91.4% increase from the previous year [3] - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Profound Medical operates within the Zacks Medical - Drugs industry, where Rigel Pharmaceuticals (RIGL) also holds a Zacks Rank of 3 (Hold) and has seen a 3.4% decrease in its share price [4][5] - Rigel's consensus EPS estimate for its upcoming report is $1.17, representing a 46.3% increase from the previous year, with its stock also experiencing a decline of 6.7% over the past month [5]

Core Viewpoint - Lincoln Educational Services Corporation (LINC) shares experienced a significant increase of 6.3% to $26.71, supported by higher-than-average trading volume, reflecting positive investor sentiment and growth potential [1][2]. Company Performance - The stock's recent performance includes a 7.8% gain over the past four weeks, indicating a strong upward trend [1]. - LINC is projected to report quarterly earnings of $0.42 per share, representing a year-over-year increase of 35.5%, with expected revenues of $132.27 million, up 10.8% from the previous year [3]. Growth Drivers - The company's focus on expanding and diversifying service offerings, along with ongoing campus developments in locations like Houston and Levittown, is expected to enhance enrollment and revenue potential [2]. - The operational leverage from the Lincoln 10.0 hybrid model has contributed to positive growth trends, further boosting investor optimism [2]. Earnings Estimates - The consensus EPS estimate for LINC has remained unchanged over the last 30 days, suggesting stability in earnings expectations [4]. - Trends in earnings estimate revisions are closely correlated with near-term stock price movements, indicating that monitoring these trends is crucial for assessing future stock performance [3][4]. Industry Context - LINC holds a Zacks Rank of 1 (Strong Buy), positioning it favorably within the Zacks Schools industry [5]. - Another company in the same industry, Adtalem Global Education (ATGE), has also shown positive performance, with a 2.4% increase in its stock price and a 14.7% return over the past month [5].

Group 1 - Calix (CALX) shares increased by 7.4% to close at $59.04, supported by high trading volume, compared to a 3.5% gain over the past four weeks [1] - The optimism for Calix is driven by strong customer demand, accelerating subscriber additions, competitive displacements, and expanding platform adoption [1] - The upcoming quarterly earnings report for Calix is expected to show earnings of $0.38 per share, reflecting a year-over-year increase of 375%, with revenues projected at $270.03 million, up 31% from the previous year [2] Group 2 - The consensus EPS estimate for Calix has remained unchanged over the last 30 days, indicating that stock price movements may not continue without trends in earnings estimate revisions [4] - Calix holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [4] - In the same industry, Confluent (CFLT) has a consensus EPS estimate of $0.1, representing an 11.1% increase year-over-year, and also holds a Zacks Rank of 3 (Hold) [5]

Core Viewpoint - Talen Energy Corporation is experiencing significant stock price movement and is expanding its asset base through a major acquisition, which is expected to enhance its financial performance and cash flow generation capabilities [1][2][3]. Group 1: Stock Performance - Talen Energy shares increased by 11.8% to close at $419.07, with trading volume significantly higher than usual [1]. - The stock has gained 6.5% over the past four weeks, indicating positive momentum [1]. Group 2: Acquisition Details - Talen Energy announced the acquisition of approximately 2.6 GW of natural gas generation assets in Ohio and Indiana for $3.45 billion, which will strengthen its position in the western PJM market [2]. - This acquisition is expected to enhance the company's capacity to support large-scale customers and is projected to be immediately accretive to adjusted free cash flow per share [3]. Group 3: Financial Expectations - The company is anticipated to report quarterly earnings of $2.82 per share, reflecting a year-over-year increase of 55.8%, with revenues expected to reach $690.13 million, up 47.8% from the previous year [4]. - The consensus EPS estimate for the quarter has been revised 31.6% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [5]. Group 4: Industry Context - Talen Energy operates within the Zacks Alternative Energy - Other industry, where Excelerate Energy, another company in the sector, has also shown positive stock performance [6]. - Excelerate Energy's EPS estimate has remained unchanged, reflecting a year-over-year decline of 27.5%, and it currently holds a Zacks Rank of 3 (Hold) [7].

Core Insights - Quantum Corp. (QMCO) shares increased by 5.6% to $7.91, with trading volume higher than average, contrasting with a 0.9% gain over the past four weeks [1] Financial Performance - QMCO anticipates third-quarter fiscal 2026 revenues of $72.7 million, exceeding the guided range of $67 million (+/- $2 million) [2] - Non-GAAP adjusted operating expenses are projected at $26.9 million, within the guided range of $25 million (+/- $2 million) [2] - GAAP gross margin is expected to be 38% [2] - The company is projected to report a quarterly loss of $0.45 per share, reflecting a year-over-year change of +44.4% [3] - Revenues for the upcoming report are expected to be $66.7 million, down 8.1% from the same quarter last year [3] Market Trends - Trends in earnings estimate revisions are strongly correlated with near-term stock price movements, indicating potential strength in stock performance [4] - The consensus EPS estimate for QMCO has remained unchanged over the last 30 days, suggesting that stock price movements may stabilize without earnings estimate revisions [5] - QMCO currently holds a Zacks Rank of 3 (Hold), while Teradata (TDC), a competitor, has a Zacks Rank of 2 (Buy) and has seen a 1% increase in its stock price [5][6]

Company Overview - Ichor Holdings (ICHR) shares increased by 6.9% to $27.92 in the last trading session, with a notable trading volume, and have gained 48.8% over the past four weeks, driven by strong demand for etch and deposition applications [1] - The company is expected to report a quarterly loss of $0.06 per share, reflecting a year-over-year decline of 175%, with revenues projected at $220.95 million, down 5.3% from the previous year [2] Earnings Estimates - The consensus EPS estimate for Ichor Holdings has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] - SkyWater Technology, another company in the same industry, has a consensus EPS estimate of -$0.01, representing a 125% decline from the previous year [4] Industry Context - Ichor Holdings operates within the Zacks Electronics - Semiconductors industry, which is currently experiencing strong demand due to investments in advanced technologies [1] - SkyWater Technology has also shown significant performance, closing 4% higher at $30.44 and achieving a 79.4% return in the past month [3]

Group 1 - Marex Group PLC (MRX) shares have increased by 1.2% over the past four weeks, closing at $39.15, with a mean price target of $50.29 indicating a potential upside of 28.5% [1] - The average price targets from analysts range from a low of $36.00 to a high of $61.00, with a standard deviation of $8.48, suggesting variability in estimates [2] - Analysts are optimistic about MRX's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for MRX has increased by 1.6% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - MRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be reliable for predicting the extent of MRX's gains, they can provide guidance on the direction of price movement [14]